Nesina (alogliptin) Tablets, for Oral Use
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
April 2016
WARNINGS AND PRECAUTIONS
Pancreatitis
Acute pancreatitis has been reported in the postmarketing setting and in...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts